Payer
The company will use the funds to augment key content partnerships.
The company will use the funds to move into the female health space and increase screening and preventive care.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
In a panel discussion, experts emphasized that AI must align with clinical workflows, reduce cognitive load, and support – not replace – clinicians.
The company will use the funds to increase the adoption of its new offering, Sage, across healthcare providers, payers and care management organizations.
HIMSS25
As AI technology continues to evolve, Abhinav Shashank, Innovaccer CEO, says IT leaders must stay focused on ensuring that all AI tools are ethically trained, tested and deployed and that their desired outcomes are clearly defined.
Curai patients will be referred to Rula’s network of mental health providers.
The company will use the funds to bring its disease management platform to more markets.